par Lohrisch, C;Piccart-Gebhart, Martine
Référence Clinical breast cancer, 2, 2, page (129-35; discussion 136-7)
Publication Publié, 2001-07
Référence Clinical breast cancer, 2, 2, page (129-35; discussion 136-7)
Publication Publié, 2001-07
Article révisé par les pairs
Titre: |
|
Auteur: | Lohrisch, C; Piccart-Gebhart, Martine |
Informations sur la publication: | Clinical breast cancer, 2, 2, page (129-35; discussion 136-7) |
Statut de publication: | Publié, 2001-07 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Animals |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- metabolism | |
Breast Neoplasms -- mortality | |
Clinical Trials as Topic | |
Female | |
Humans | |
Prognosis | |
Receptor, erbB-2 -- metabolism | |
Survival Rate | |
Treatment Outcome | |
Up-Regulation | |
Note générale: | Journal Article |
Research Support, Non-U.S. Gov't | |
Review | |
Langue: | Anglais |
Identificateurs: | urn:issn:1526-8209 |
info:pmid/11899784 |